The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma HemoglobinRussell P. Rother, Mark T. Gladwin, Leonard Bell et al.|JAMA|2005Cited by 1.5k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal HemoglobinuriaPeter Hillmen, Lucio Luzzatto, Modupe Elebute et al.|New England Journal of Medicine|2006Cited by 1.3k
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuriaRobert A. Brodsky, Peter Hillmen, Neal S. Young et al.|Blood|2007Cited by 653
Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal HemoglobinuriaPeter Hillmen, Russell P. Rother, Claire Hall et al.|New England Journal of Medicine|2004Cited by 637
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuriaPeter Hillmen, Neal S. Young, Petra Muus et al.|Blood|2007Cited by 578